| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterine Neoplasms | 43 | 2023 | 1423 | 3.090 |
Why?
|
| Leiomyoma | 27 | 2023 | 641 | 2.270 |
Why?
|
| Leiomyosarcoma | 16 | 2023 | 425 | 1.660 |
Why?
|
| Adenosarcoma | 3 | 2017 | 36 | 1.130 |
Why?
|
| Smooth Muscle Tumor | 5 | 2023 | 65 | 0.860 |
Why?
|
| Translocation, Genetic | 16 | 2023 | 1395 | 0.840 |
Why?
|
| Leiomyomatosis | 6 | 2022 | 69 | 0.800 |
Why?
|
| Endometrial Neoplasms | 9 | 2023 | 1382 | 0.720 |
Why?
|
| Chromosome Aberrations | 11 | 2017 | 1781 | 0.700 |
Why?
|
| Chromosomes, Human, Pair 8 | 4 | 2017 | 453 | 0.680 |
Why?
|
| Neurotransmitter Agents | 2 | 2021 | 666 | 0.620 |
Why?
|
| Placenta | 8 | 2024 | 1724 | 0.610 |
Why?
|
| HMGA2 Protein | 7 | 2012 | 101 | 0.570 |
Why?
|
| Mixed Tumor, Mullerian | 1 | 2017 | 55 | 0.550 |
Why?
|
| Nerve Tissue Proteins | 6 | 2021 | 4417 | 0.530 |
Why?
|
| Neoplasm Seeding | 2 | 2013 | 85 | 0.520 |
Why?
|
| Chromosomes, Human, Pair 12 | 5 | 2004 | 431 | 0.500 |
Why?
|
| Choriocarcinoma | 3 | 2017 | 121 | 0.460 |
Why?
|
| Endometrial Stromal Tumors | 1 | 2013 | 46 | 0.420 |
Why?
|
| Endometrium | 9 | 2023 | 407 | 0.420 |
Why?
|
| Hydatidiform Mole | 3 | 2020 | 255 | 0.420 |
Why?
|
| Uterine Cervical Dysplasia | 4 | 2018 | 387 | 0.410 |
Why?
|
| Peritoneum | 1 | 2012 | 231 | 0.380 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2004 | 277 | 0.370 |
Why?
|
| Uterine Cervical Neoplasms | 8 | 2018 | 2040 | 0.360 |
Why?
|
| Antigens, Differentiation | 1 | 2013 | 919 | 0.350 |
Why?
|
| Uterus | 8 | 2024 | 660 | 0.350 |
Why?
|
| Placenta Diseases | 2 | 2023 | 199 | 0.340 |
Why?
|
| Myometrium | 6 | 2012 | 174 | 0.340 |
Why?
|
| In Situ Hybridization, Fluorescence | 19 | 2018 | 2525 | 0.330 |
Why?
|
| Stromal Cells | 3 | 2015 | 1335 | 0.320 |
Why?
|
| Fallopian Tubes | 1 | 2010 | 179 | 0.320 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2010 | 117 | 0.320 |
Why?
|
| Pelvic Neoplasms | 2 | 2022 | 250 | 0.310 |
Why?
|
| SNARE Proteins | 3 | 2017 | 80 | 0.310 |
Why?
|
| DNA Copy Number Variations | 3 | 2023 | 2046 | 0.300 |
Why?
|
| Kallmann Syndrome | 3 | 2023 | 142 | 0.290 |
Why?
|
| Synaptic Vesicles | 2 | 2021 | 190 | 0.290 |
Why?
|
| Immunohistochemistry | 19 | 2022 | 11139 | 0.280 |
Why?
|
| Chromosome Breakage | 7 | 2012 | 159 | 0.260 |
Why?
|
| Karyotyping | 11 | 2018 | 1173 | 0.260 |
Why?
|
| Hysterectomy | 8 | 2024 | 863 | 0.260 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2022 | 2181 | 0.240 |
Why?
|
| Cell Membrane | 4 | 2021 | 3663 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2019 | 18047 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2007 | 419 | 0.230 |
Why?
|
| Female | 91 | 2024 | 396926 | 0.220 |
Why?
|
| Loss of Heterozygosity | 3 | 2010 | 663 | 0.220 |
Why?
|
| Peritoneal Neoplasms | 3 | 2013 | 715 | 0.220 |
Why?
|
| Acetyltransferases | 1 | 2004 | 231 | 0.210 |
Why?
|
| Trophoblasts | 3 | 2023 | 224 | 0.210 |
Why?
|
| Agrin | 1 | 2023 | 75 | 0.210 |
Why?
|
| Neurons | 3 | 2021 | 9504 | 0.210 |
Why?
|
| DNA Helicases | 1 | 2008 | 853 | 0.210 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2018 | 1614 | 0.200 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2017 | 2964 | 0.200 |
Why?
|
| Papillomaviridae | 4 | 2003 | 1135 | 0.200 |
Why?
|
| Craniofacial Abnormalities | 3 | 2012 | 320 | 0.200 |
Why?
|
| Endometrial Hyperplasia | 1 | 2023 | 99 | 0.200 |
Why?
|
| Receptors, Cholinergic | 1 | 2023 | 244 | 0.200 |
Why?
|
| Placenta Previa | 1 | 2024 | 126 | 0.200 |
Why?
|
| Cyclin E | 2 | 2001 | 156 | 0.200 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2018 | 711 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 3 | 3 | 2007 | 323 | 0.200 |
Why?
|
| Computational Biology | 2 | 2013 | 3549 | 0.190 |
Why?
|
| Papillomavirus Infections | 4 | 2018 | 1637 | 0.190 |
Why?
|
| Gene Expression Profiling | 7 | 2019 | 9508 | 0.190 |
Why?
|
| Ovarian Neoplasms | 5 | 2021 | 4906 | 0.190 |
Why?
|
| Chromosome Deletion | 5 | 2012 | 1390 | 0.180 |
Why?
|
| Dermoid Cyst | 1 | 2021 | 92 | 0.180 |
Why?
|
| Myxoma | 1 | 2001 | 114 | 0.180 |
Why?
|
| Scoliosis | 1 | 2008 | 793 | 0.180 |
Why?
|
| Mediator Complex | 2 | 2018 | 106 | 0.180 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2019 | 2847 | 0.180 |
Why?
|
| Dosage Compensation, Genetic | 2 | 2002 | 209 | 0.180 |
Why?
|
| Syntaxin 1 | 1 | 2020 | 29 | 0.170 |
Why?
|
| Vaginal Smears | 1 | 2003 | 501 | 0.170 |
Why?
|
| Phosphoproteins | 4 | 2002 | 2450 | 0.170 |
Why?
|
| Sarcoma, Endometrial Stromal | 1 | 2001 | 93 | 0.170 |
Why?
|
| Humans | 107 | 2024 | 768369 | 0.170 |
Why?
|
| Placenta Accreta | 1 | 2024 | 241 | 0.170 |
Why?
|
| Vulvar Neoplasms | 2 | 2003 | 267 | 0.170 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2001 | 239 | 0.170 |
Why?
|
| High Mobility Group Proteins | 4 | 2002 | 179 | 0.170 |
Why?
|
| Trans-Activators | 4 | 2002 | 2858 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2009 | 8636 | 0.160 |
Why?
|
| Adenomyoma | 1 | 2018 | 8 | 0.160 |
Why?
|
| Candida albicans | 1 | 2022 | 376 | 0.160 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2019 | 72 | 0.160 |
Why?
|
| Ki-67 Antigen | 4 | 2003 | 631 | 0.160 |
Why?
|
| Teratoma | 1 | 2021 | 405 | 0.160 |
Why?
|
| Serine Proteases | 1 | 2018 | 50 | 0.160 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2021 | 583 | 0.150 |
Why?
|
| Intracellular Membranes | 1 | 2019 | 388 | 0.150 |
Why?
|
| Adult | 43 | 2023 | 223528 | 0.150 |
Why?
|
| Pregnancy | 17 | 2024 | 30179 | 0.150 |
Why?
|
| Polyps | 2 | 2015 | 200 | 0.150 |
Why?
|
| Stillbirth | 1 | 2021 | 376 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2008 | 3793 | 0.150 |
Why?
|
| Carcinoma | 3 | 2019 | 2341 | 0.150 |
Why?
|
| Cell Differentiation | 4 | 2013 | 11674 | 0.150 |
Why?
|
| Munc18 Proteins | 1 | 2017 | 20 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 7 | 3 | 2009 | 310 | 0.140 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2023 | 520 | 0.140 |
Why?
|
| Fallopian Tube Neoplasms | 2 | 2010 | 329 | 0.140 |
Why?
|
| R-SNARE Proteins | 1 | 2017 | 73 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 1489 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2020 | 1409 | 0.140 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2018 | 211 | 0.140 |
Why?
|
| Lanthanoid Series Elements | 1 | 2016 | 17 | 0.140 |
Why?
|
| Genome-Wide Association Study | 3 | 2018 | 12771 | 0.140 |
Why?
|
| Papillomavirus Vaccines | 1 | 2003 | 497 | 0.140 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2016 | 510 | 0.140 |
Why?
|
| Fibrosarcoma | 1 | 2018 | 313 | 0.140 |
Why?
|
| Abnormalities, Multiple | 4 | 2007 | 1424 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 2 | 3 | 2008 | 313 | 0.130 |
Why?
|
| Liposarcoma | 1 | 2019 | 289 | 0.130 |
Why?
|
| DNA-Binding Proteins | 6 | 2009 | 9623 | 0.130 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2018 | 501 | 0.130 |
Why?
|
| Gene Fusion | 1 | 2018 | 356 | 0.130 |
Why?
|
| Vascular Neoplasms | 2 | 2016 | 167 | 0.130 |
Why?
|
| Cystadenocarcinoma, Serous | 2 | 2010 | 480 | 0.130 |
Why?
|
| Membrane Fusion | 1 | 2017 | 265 | 0.130 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2002 | 1494 | 0.120 |
Why?
|
| Trophoblastic Neoplasms | 1 | 2015 | 89 | 0.120 |
Why?
|
| Mutation | 8 | 2021 | 30235 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2007 | 640 | 0.120 |
Why?
|
| Endometriosis | 4 | 2004 | 873 | 0.120 |
Why?
|
| GATA3 Transcription Factor | 1 | 2015 | 164 | 0.120 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2015 | 67 | 0.120 |
Why?
|
| Membrane Proteins | 5 | 2023 | 7895 | 0.120 |
Why?
|
| Genital Neoplasms, Female | 2 | 2014 | 539 | 0.110 |
Why?
|
| Receptors, Estrogen | 3 | 2023 | 2243 | 0.110 |
Why?
|
| Chromosome Mapping | 8 | 2008 | 4622 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 14 | 4 | 2003 | 286 | 0.110 |
Why?
|
| Pre-Eclampsia | 1 | 2023 | 1257 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2002 | 1162 | 0.110 |
Why?
|
| Immunophenotyping | 4 | 2010 | 1868 | 0.110 |
Why?
|
| Germ-Line Mutation | 2 | 2013 | 1884 | 0.110 |
Why?
|
| Chromosome Banding | 2 | 2004 | 261 | 0.110 |
Why?
|
| Rats | 6 | 2020 | 23839 | 0.110 |
Why?
|
| Perivascular Epithelioid Cell Neoplasms | 1 | 2014 | 78 | 0.100 |
Why?
|
| p21-Activated Kinases | 1 | 2013 | 127 | 0.100 |
Why?
|
| Adenoma | 1 | 2023 | 2163 | 0.100 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2018 | 783 | 0.100 |
Why?
|
| Middle Aged | 30 | 2022 | 223406 | 0.100 |
Why?
|
| Precancerous Conditions | 1 | 1998 | 988 | 0.100 |
Why?
|
| Necrosis | 3 | 2022 | 1622 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2882 | 0.090 |
Why?
|
| Databases, Protein | 1 | 2013 | 387 | 0.090 |
Why?
|
| Focal Adhesions | 1 | 2011 | 114 | 0.090 |
Why?
|
| Ultrasonic Therapy | 2 | 2003 | 217 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2012 | 410 | 0.090 |
Why?
|
| Genomics | 2 | 2019 | 5912 | 0.090 |
Why?
|
| Predictive Value of Tests | 6 | 2018 | 15459 | 0.090 |
Why?
|
| Neoplasm Proteins | 2 | 2010 | 3611 | 0.090 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2012 | 219 | 0.090 |
Why?
|
| Connexin 43 | 1 | 2011 | 202 | 0.090 |
Why?
|
| Antibodies | 2 | 2018 | 2426 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2018 | 9425 | 0.090 |
Why?
|
| Comparative Genomic Hybridization | 3 | 2023 | 474 | 0.090 |
Why?
|
| Genes, BRCA2 | 1 | 2013 | 592 | 0.090 |
Why?
|
| Chickens | 1 | 2012 | 860 | 0.090 |
Why?
|
| PAX2 Transcription Factor | 1 | 2010 | 86 | 0.090 |
Why?
|
| Lipoma | 2 | 2004 | 296 | 0.090 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 1112 | 0.090 |
Why?
|
| Gap Junctions | 1 | 2011 | 230 | 0.090 |
Why?
|
| Genes, BRCA1 | 1 | 2013 | 755 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2017 | 3783 | 0.080 |
Why?
|
| Chromosome Disorders | 1 | 2012 | 499 | 0.080 |
Why?
|
| Tumor Virus Infections | 3 | 2003 | 438 | 0.080 |
Why?
|
| ras Proteins | 2 | 2024 | 1058 | 0.080 |
Why?
|
| Animals | 22 | 2024 | 169424 | 0.080 |
Why?
|
| Mice | 14 | 2024 | 82051 | 0.080 |
Why?
|
| Disease Models, Animal | 4 | 2012 | 18390 | 0.080 |
Why?
|
| Receptors, Fibroblast Growth Factor | 2 | 2001 | 196 | 0.080 |
Why?
|
| Prognosis | 7 | 2022 | 30031 | 0.080 |
Why?
|
| Gene Rearrangement | 3 | 2007 | 1139 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 1999 | 370 | 0.080 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 738 | 0.080 |
Why?
|
| Hirsutism | 1 | 2008 | 68 | 0.080 |
Why?
|
| Cytogenetic Analysis | 4 | 2016 | 270 | 0.080 |
Why?
|
| Diagnosis, Differential | 7 | 2017 | 13025 | 0.080 |
Why?
|
| DNA Mutational Analysis | 4 | 2010 | 4120 | 0.070 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2008 | 84 | 0.070 |
Why?
|
| DNA Primers | 3 | 2008 | 2825 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 5709 | 0.070 |
Why?
|
| Histone Deacetylases | 1 | 2012 | 717 | 0.070 |
Why?
|
| Uterine Hemorrhage | 3 | 2016 | 240 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2014 | 1608 | 0.070 |
Why?
|
| NFI Transcription Factors | 1 | 2007 | 42 | 0.070 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2022 | 3198 | 0.070 |
Why?
|
| Genes, p53 | 1 | 2010 | 716 | 0.070 |
Why?
|
| Gingival Hyperplasia | 1 | 2007 | 19 | 0.070 |
Why?
|
| Cluster Analysis | 4 | 2012 | 2730 | 0.070 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 3 | 2023 | 1628 | 0.070 |
Why?
|
| Mass Screening | 1 | 2003 | 5455 | 0.070 |
Why?
|
| Diacylglycerol Kinase | 1 | 2007 | 47 | 0.070 |
Why?
|
| Haploidy | 1 | 2007 | 127 | 0.070 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 600 | 0.070 |
Why?
|
| Hypertrichosis | 1 | 2007 | 31 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2021 | 19035 | 0.070 |
Why?
|
| Human Development | 1 | 2008 | 123 | 0.070 |
Why?
|
| Aged | 17 | 2019 | 171514 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2004 | 2819 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2008 | 361 | 0.070 |
Why?
|
| Mosaicism | 2 | 2009 | 481 | 0.070 |
Why?
|
| Chromosomes, Human, X | 1 | 2008 | 321 | 0.070 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2005 | 259 | 0.070 |
Why?
|
| Decidua | 1 | 2006 | 82 | 0.060 |
Why?
|
| Infarction | 2 | 2023 | 249 | 0.060 |
Why?
|
| Aged, 80 and over | 6 | 2018 | 59679 | 0.060 |
Why?
|
| Chromosomes, Human, Y | 1 | 2007 | 163 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2022 | 4299 | 0.060 |
Why?
|
| Microsatellite Repeats | 2 | 1999 | 784 | 0.060 |
Why?
|
| Disease Progression | 2 | 2020 | 13643 | 0.060 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2008 | 259 | 0.060 |
Why?
|
| Germ Cells | 2 | 2018 | 641 | 0.060 |
Why?
|
| Mitotic Index | 2 | 2016 | 164 | 0.060 |
Why?
|
| Congenital Abnormalities | 2 | 2008 | 708 | 0.060 |
Why?
|
| Nervous System Malformations | 1 | 2007 | 244 | 0.060 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2008 | 738 | 0.060 |
Why?
|
| Cataract | 1 | 2011 | 837 | 0.060 |
Why?
|
| DNA, Neoplasm | 3 | 2002 | 1749 | 0.060 |
Why?
|
| Fibronectins | 1 | 1988 | 725 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1615 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1755 | 0.060 |
Why?
|
| Genes, Neoplasm | 2 | 2004 | 371 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2002 | 1064 | 0.060 |
Why?
|
| Embryonic and Fetal Development | 2 | 2002 | 420 | 0.060 |
Why?
|
| Biopsy | 4 | 2019 | 6816 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2020 | 3806 | 0.060 |
Why?
|
| Genetic Markers | 2 | 2020 | 2604 | 0.060 |
Why?
|
| Keratin-14 | 2 | 2001 | 57 | 0.060 |
Why?
|
| Urogenital Abnormalities | 1 | 2007 | 255 | 0.060 |
Why?
|
| Cell Line | 5 | 2011 | 15610 | 0.060 |
Why?
|
| Receptors, Immunologic | 2 | 2007 | 1411 | 0.060 |
Why?
|
| Autistic Disorder | 3 | 2012 | 1240 | 0.060 |
Why?
|
| raf Kinases | 1 | 2024 | 118 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2001 | 4083 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2007 | 624 | 0.060 |
Why?
|
| Carcinoma, Adenosquamous | 2 | 2001 | 66 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 5891 | 0.050 |
Why?
|
| Urinary Tract | 1 | 2007 | 305 | 0.050 |
Why?
|
| Fetal Growth Retardation | 2 | 2006 | 585 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2023 | 1119 | 0.050 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2007 | 433 | 0.050 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2023 | 119 | 0.050 |
Why?
|
| Sensitivity and Specificity | 4 | 2018 | 14725 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 458 | 0.050 |
Why?
|
| Fumarate Hydratase | 1 | 2022 | 55 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
| Urogenital System | 1 | 2002 | 88 | 0.050 |
Why?
|
| Keratins | 2 | 2001 | 502 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2004 | 335 | 0.050 |
Why?
|
| Rad51 Recombinase | 1 | 2003 | 191 | 0.050 |
Why?
|
| Neuropeptides | 1 | 2008 | 950 | 0.050 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2001 | 595 | 0.050 |
Why?
|
| Disease-Free Survival | 3 | 2019 | 6856 | 0.050 |
Why?
|
| Genome, Human | 2 | 2008 | 4454 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2008 | 3612 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2024 | 639 | 0.050 |
Why?
|
| RNA, Neoplasm | 1 | 2004 | 751 | 0.050 |
Why?
|
| Desmin | 1 | 2001 | 99 | 0.050 |
Why?
|
| Adolescent | 5 | 2023 | 89163 | 0.050 |
Why?
|
| Base Sequence | 3 | 2008 | 12426 | 0.050 |
Why?
|
| Biophysical Phenomena | 1 | 2021 | 321 | 0.050 |
Why?
|
| Adenocarcinoma | 4 | 2003 | 6400 | 0.040 |
Why?
|
| Neuromuscular Junction | 1 | 2023 | 406 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 3 | 2012 | 4774 | 0.040 |
Why?
|
| Neoplasm Staging | 3 | 2022 | 11249 | 0.040 |
Why?
|
| Alternative Splicing | 2 | 2003 | 1094 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2008 | 2207 | 0.040 |
Why?
|
| Gynecology | 2 | 2019 | 532 | 0.040 |
Why?
|
| Observer Variation | 2 | 2019 | 2622 | 0.040 |
Why?
|
| DNA Damage | 1 | 2010 | 2461 | 0.040 |
Why?
|
| Neprilysin | 1 | 2003 | 487 | 0.040 |
Why?
|
| Cleft Lip | 1 | 2005 | 513 | 0.040 |
Why?
|
| Cerebellar Neoplasms | 1 | 2004 | 589 | 0.040 |
Why?
|
| Phenotype | 4 | 2018 | 16712 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2020 | 3972 | 0.040 |
Why?
|
| RNA Helicases | 1 | 2000 | 144 | 0.040 |
Why?
|
| Adnexa Uteri | 1 | 2019 | 40 | 0.040 |
Why?
|
| Cleft Palate | 1 | 2005 | 598 | 0.040 |
Why?
|
| Retrospective Studies | 10 | 2024 | 81835 | 0.040 |
Why?
|
| Developmental Disabilities | 1 | 2008 | 1516 | 0.040 |
Why?
|
| Fetal Death | 1 | 2021 | 438 | 0.040 |
Why?
|
| Mice, Knockout | 4 | 2021 | 14483 | 0.040 |
Why?
|
| Tumor Burden | 2 | 2016 | 1909 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2023 | 906 | 0.040 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 330 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 434 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2016 | 2889 | 0.040 |
Why?
|
| DNA, Viral | 3 | 2001 | 2203 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2022 | 41782 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2003 | 12813 | 0.040 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2002 | 895 | 0.040 |
Why?
|
| Omentum | 1 | 2019 | 168 | 0.040 |
Why?
|
| Ploidies | 1 | 2019 | 287 | 0.040 |
Why?
|
| Clone Cells | 1 | 2002 | 1672 | 0.040 |
Why?
|
| Online Systems | 1 | 2019 | 182 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2023 | 1145 | 0.040 |
Why?
|
| Young Adult | 4 | 2021 | 60038 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2003 | 1196 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 7602 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 2001 | 1706 | 0.040 |
Why?
|
| Cysteine | 1 | 2022 | 895 | 0.040 |
Why?
|
| Cicatrix | 1 | 2024 | 799 | 0.040 |
Why?
|
| Veins | 1 | 2002 | 767 | 0.040 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1997 | 69 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 53 | 0.040 |
Why?
|
| Calorimetry | 1 | 2017 | 132 | 0.040 |
Why?
|
| Mucins | 1 | 2000 | 570 | 0.040 |
Why?
|
| RNA | 2 | 2004 | 2728 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2023 | 24310 | 0.030 |
Why?
|
| Biological Transport | 1 | 2021 | 2090 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2001 | 930 | 0.030 |
Why?
|
| Cervix Uteri | 1 | 2001 | 577 | 0.030 |
Why?
|
| Self Disclosure | 1 | 2018 | 249 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11844 | 0.030 |
Why?
|
| Telomere | 1 | 2003 | 942 | 0.030 |
Why?
|
| Syndrome | 3 | 2007 | 3278 | 0.030 |
Why?
|
| Sarcoma | 1 | 2007 | 1806 | 0.030 |
Why?
|
| Epithelium | 1 | 2001 | 1610 | 0.030 |
Why?
|
| Neoplasms | 2 | 2024 | 22389 | 0.030 |
Why?
|
| Epithelial Cells | 3 | 2002 | 3697 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 11206 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2024 | 3619 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2019 | 329 | 0.030 |
Why?
|
| Atrophy | 1 | 2001 | 1648 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2021 | 1173 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 2016 | 395 | 0.030 |
Why?
|
| Fetus | 2 | 2000 | 1883 | 0.030 |
Why?
|
| Carcinoma in Situ | 1 | 2001 | 791 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2020 | 1032 | 0.030 |
Why?
|
| Aging | 2 | 2012 | 8762 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2024 | 1414 | 0.030 |
Why?
|
| Point Mutation | 1 | 2020 | 1596 | 0.030 |
Why?
|
| Freeze Fracturing | 2 | 2011 | 70 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2023 | 23639 | 0.030 |
Why?
|
| Human Genome Project | 2 | 2008 | 201 | 0.030 |
Why?
|
| Cell Communication | 1 | 2021 | 1662 | 0.030 |
Why?
|
| Cerebellum | 1 | 2021 | 1515 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2015 | 5042 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2021 | 1359 | 0.030 |
Why?
|
| Seizures | 1 | 2007 | 2996 | 0.030 |
Why?
|
| X Chromosome | 1 | 1997 | 819 | 0.030 |
Why?
|
| Molecular Sequence Data | 5 | 2007 | 17637 | 0.030 |
Why?
|
| Oviducts | 1 | 2012 | 11 | 0.030 |
Why?
|
| Wnt Proteins | 2 | 2007 | 724 | 0.030 |
Why?
|
| Decision Trees | 1 | 1995 | 510 | 0.030 |
Why?
|
| Poultry Diseases | 1 | 2012 | 26 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2011 | 3790 | 0.030 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2012 | 29 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 17149 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2001 | 2942 | 0.030 |
Why?
|
| Permeability | 1 | 2014 | 725 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 2009 | 6087 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2014 | 694 | 0.020 |
Why?
|
| Filipin | 1 | 2011 | 14 | 0.020 |
Why?
|
| Premenopause | 3 | 2002 | 1039 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2014 | 8331 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2016 | 1906 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2020 | 2854 | 0.020 |
Why?
|
| New England | 1 | 2015 | 1056 | 0.020 |
Why?
|
| Remission Induction | 1 | 2017 | 2408 | 0.020 |
Why?
|
| Treatment Outcome | 6 | 2019 | 65408 | 0.020 |
Why?
|
| Time Factors | 4 | 2016 | 40271 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2023 | 3456 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2013 | 614 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2000 | 2575 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2016 | 979 | 0.020 |
Why?
|
| Quinazolinones | 1 | 2012 | 222 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 1997 | 1084 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2007 | 4582 | 0.020 |
Why?
|
| Male | 13 | 2019 | 364761 | 0.020 |
Why?
|
| Mitosis | 1 | 2016 | 1191 | 0.020 |
Why?
|
| Trisomy | 1 | 1992 | 261 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 2010 | 135 | 0.020 |
Why?
|
| Pandemics | 2 | 2021 | 8751 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 2011 | 251 | 0.020 |
Why?
|
| Sodium Channels | 1 | 2012 | 341 | 0.020 |
Why?
|
| Cause of Death | 1 | 2021 | 3727 | 0.020 |
Why?
|
| Heterozygote | 1 | 1997 | 2792 | 0.020 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 336 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2023 | 4948 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1992 | 534 | 0.020 |
Why?
|
| Infant, Newborn | 3 | 2021 | 26394 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 2007 | 13447 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 2012 | 6135 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2011 | 946 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3433 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 22365 | 0.020 |
Why?
|
| Receptors, Fibronectin | 1 | 1988 | 37 | 0.020 |
Why?
|
| Hippocampus | 1 | 2021 | 3783 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2013 | 1685 | 0.020 |
Why?
|
| Nervous System | 1 | 2012 | 547 | 0.020 |
Why?
|
| Leiomyoma, Epithelioid | 1 | 2008 | 3 | 0.020 |
Why?
|
| Pathology, Clinical | 1 | 2012 | 377 | 0.020 |
Why?
|
| Risk Factors | 4 | 2015 | 74915 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6537 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 4931 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 1688 | 0.020 |
Why?
|
| Prevalence | 2 | 2018 | 15879 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 3669 | 0.020 |
Why?
|
| Mutation, Missense | 2 | 2008 | 2590 | 0.020 |
Why?
|
| Gene Expression | 1 | 2001 | 7605 | 0.020 |
Why?
|
| Menstrual Cycle | 2 | 2002 | 542 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2003 | 1992 | 0.020 |
Why?
|
| Limb Deformities, Congenital | 2 | 2003 | 136 | 0.020 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2007 | 84 | 0.020 |
Why?
|
| Peptide Fragments | 2 | 2011 | 5151 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 2896 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 1339 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2011 | 1083 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 1742 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 1987 | 197 | 0.020 |
Why?
|
| Transcription Factors | 3 | 2001 | 12176 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2011 | 1207 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 1997 | 4247 | 0.020 |
Why?
|
| Disulfides | 1 | 1988 | 467 | 0.020 |
Why?
|
| Factor VIII | 1 | 1988 | 349 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2019 | 3954 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1988 | 2173 | 0.020 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1993 | 798 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2007 | 777 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 20232 | 0.020 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2005 | 20 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2007 | 4132 | 0.020 |
Why?
|
| Child | 4 | 2024 | 80856 | 0.020 |
Why?
|
| Lens, Crystalline | 1 | 1987 | 387 | 0.020 |
Why?
|
| Calcium Channels, L-Type | 1 | 2007 | 242 | 0.020 |
Why?
|
| Immunoassay | 1 | 1988 | 746 | 0.020 |
Why?
|
| Boston | 1 | 2018 | 9359 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2007 | 4534 | 0.010 |
Why?
|
| Brain Neoplasms | 2 | 2004 | 9177 | 0.010 |
Why?
|
| Ureter | 1 | 2007 | 370 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2014 | 5441 | 0.010 |
Why?
|
| Meningeal Neoplasms | 1 | 1993 | 1251 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2023 | 54913 | 0.010 |
Why?
|
| Piperidines | 1 | 2012 | 1664 | 0.010 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1992 | 1767 | 0.010 |
Why?
|
| Chromosome Fragility | 1 | 2003 | 16 | 0.010 |
Why?
|
| Chromosome Fragile Sites | 1 | 2003 | 26 | 0.010 |
Why?
|
| Genes, Overlapping | 1 | 2003 | 36 | 0.010 |
Why?
|
| Face | 2 | 2004 | 1031 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2011 | 2611 | 0.010 |
Why?
|
| Euchromatin | 1 | 2003 | 54 | 0.010 |
Why?
|
| Pseudogenes | 1 | 2003 | 104 | 0.010 |
Why?
|
| Reoperation | 1 | 2013 | 4342 | 0.010 |
Why?
|
| Maternal Age | 1 | 2006 | 809 | 0.010 |
Why?
|
| DNA Methylation | 1 | 1997 | 4425 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 2003 | 250 | 0.010 |
Why?
|
| Clitoris | 1 | 2002 | 35 | 0.010 |
Why?
|
| Cholesterol | 1 | 2011 | 2910 | 0.010 |
Why?
|
| Aneuploidy | 1 | 2006 | 572 | 0.010 |
Why?
|
| Gene Duplication | 1 | 2003 | 314 | 0.010 |
Why?
|
| Retroelements | 1 | 2003 | 164 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 6527 | 0.010 |
Why?
|
| Hysteroscopy | 1 | 2002 | 62 | 0.010 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2002 | 114 | 0.010 |
Why?
|
| Radiation Hybrid Mapping | 1 | 2001 | 18 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7449 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 2001 | 96 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 1674 | 0.010 |
Why?
|
| Genomic Imprinting | 1 | 2003 | 324 | 0.010 |
Why?
|
| Body Temperature Regulation | 1 | 2003 | 292 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2007 | 1337 | 0.010 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2001 | 125 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2003 | 413 | 0.010 |
Why?
|
| Williams Syndrome | 1 | 2003 | 195 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1993 | 2254 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 9261 | 0.010 |
Why?
|
| Carcinoma, Large Cell | 1 | 2001 | 114 | 0.010 |
Why?
|
| Zebrafish | 1 | 2012 | 3038 | 0.010 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2002 | 283 | 0.010 |
Why?
|
| Gonads | 1 | 2000 | 109 | 0.010 |
Why?
|
| Collagen | 1 | 1988 | 2646 | 0.010 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 2000 | 69 | 0.010 |
Why?
|
| Physical Chromosome Mapping | 1 | 2000 | 183 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2005 | 1136 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2003 | 36840 | 0.010 |
Why?
|
| Metaplasia | 1 | 2001 | 326 | 0.010 |
Why?
|
| Growth Disorders | 1 | 2004 | 635 | 0.010 |
Why?
|
| Anal Canal | 1 | 2002 | 376 | 0.010 |
Why?
|
| Pedigree | 1 | 2007 | 4545 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2000 | 387 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2007 | 1814 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2015 | 10490 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2010 | 2056 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1998 | 421 | 0.010 |
Why?
|
| Analgesia | 1 | 2003 | 461 | 0.010 |
Why?
|
| Parity | 1 | 2002 | 939 | 0.010 |
Why?
|
| CpG Islands | 1 | 2003 | 1211 | 0.010 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2003 | 604 | 0.010 |
Why?
|
| Estrogen Receptor beta | 1 | 1998 | 171 | 0.010 |
Why?
|
| DNA Probes | 1 | 1998 | 542 | 0.010 |
Why?
|
| Birth Weight | 1 | 2006 | 2117 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1999 | 1553 | 0.010 |
Why?
|
| Genotype | 1 | 2012 | 13045 | 0.010 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2000 | 384 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2015 | 22286 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2002 | 1503 | 0.010 |
Why?
|
| Brain | 1 | 2024 | 27439 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2001 | 1775 | 0.010 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2001 | 342 | 0.010 |
Why?
|
| Benzodiazepines | 1 | 2003 | 1139 | 0.010 |
Why?
|
| Gestational Age | 1 | 2006 | 3615 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2012 | 42620 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2002 | 2696 | 0.010 |
Why?
|
| Protein Binding | 1 | 1988 | 9376 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 2910 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2007 | 4180 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2000 | 2184 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2003 | 1754 | 0.010 |
Why?
|
| Kidney | 2 | 2007 | 7064 | 0.010 |
Why?
|
| Carcinoma, Papillary | 1 | 2001 | 792 | 0.010 |
Why?
|
| Menstruation | 1 | 1997 | 310 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2000 | 1974 | 0.010 |
Why?
|
| Oocytes | 1 | 2000 | 1168 | 0.010 |
Why?
|
| Algorithms | 1 | 2016 | 14157 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 4174 | 0.010 |
Why?
|
| Equipment Design | 1 | 2003 | 3530 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2003 | 3637 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 2279 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2012 | 6987 | 0.010 |
Why?
|
| United States | 1 | 2021 | 73120 | 0.010 |
Why?
|
| Postmenopause | 1 | 2002 | 2519 | 0.010 |
Why?
|
| Thrombosis | 1 | 2006 | 2954 | 0.010 |
Why?
|
| Amniocentesis | 1 | 1992 | 116 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2003 | 5308 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2002 | 4022 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2007 | 6309 | 0.010 |
Why?
|
| Reference Values | 1 | 1997 | 4941 | 0.010 |
Why?
|
| Neural Tube Defects | 1 | 1992 | 255 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 13709 | 0.010 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1993 | 595 | 0.010 |
Why?
|
| Pain | 1 | 2003 | 5096 | 0.000 |
Why?
|
| Macrophages | 1 | 2002 | 5797 | 0.000 |
Why?
|
| Cell Membrane Permeability | 1 | 1987 | 574 | 0.000 |
Why?
|
| Chick Embryo | 1 | 1987 | 978 | 0.000 |
Why?
|
| Infant | 1 | 2007 | 36496 | 0.000 |
Why?
|
| Smoking | 1 | 2002 | 9099 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1987 | 2565 | 0.000 |
Why?
|
| Body Mass Index | 1 | 2002 | 13030 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 13589 | 0.000 |
Why?
|
| Kinetics | 1 | 1987 | 6347 | 0.000 |
Why?
|
| Heart Defects, Congenital | 1 | 1992 | 4713 | 0.000 |
Why?
|
| Lung | 1 | 1992 | 10090 | 0.000 |
Why?
|